A Stuff article.
Biotechnology company Novavax has filed for provisional approval to use its Covid-19 vaccine in New Zealand.
The application is now before drug safety regulator Medsafe, the company announced in a statement.
It is the first application related to a protein-based Covid-19 vaccine to reach Medsafe.